. 2019 Sep;36(9):420-424.

A Veteran Presenting With Leg Swelling, Dyspnea, and Proteinuria

Affiliations

¹ is a Hospitalist and the Director of Resident Education at VA Boston Healthcare System and an Assistant Professor of Medicine at Harvard University in Massachusetts. He supervises the VA Boston Medical Forum chief resident case conferences. All patients or their surrogate decision makers understand and have signed appropriate patient release forms.

Jonathan Li et al. Fed Pract. 2019 Sep.

. 2019 Sep;36(9):420-424.

¹ is a Hospitalist and the Director of Resident Education at VA Boston Healthcare System and an Assistant Professor of Medicine at Harvard University in Massachusetts. He supervises the VA Boston Medical Forum chief resident case conferences. All patients or their surrogate decision makers understand and have signed appropriate patient release forms.

Erratum in

Corrections.
[No authors listed] [No authors listed] Fed Pract. 2019 Oct;36(10):447. Fed Pract. 2019. PMID: 31768094 Free PMC article.

No abstract available

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

1. Rennke H, Denker BM. Renal Pathophysiology: The Essentials. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
1. Maas RJ, Deegens JK, Smeets B, Moeller MJ, Wetzels JF. Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat Rev Nephrol. 2016;12(12):768–776. - PubMed
1. Beck LH, Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21. - PMC - PubMed
1. Rennke HG. Secondary membranoproliferative glomerulonephritis. Kidney Int. 1995;47(2):643–656. - PubMed
1. Nawaz FA, Larsen CP, Troxell ML. Membranous nephropathy and nonsteroidal anti-inflammatory agents. Am J Kidney Dis. 2013;62(5):1012–1017. - PubMed